Abstract
A patient with Glanzmann Thrombasthenia developed recurrent venous thrombosis with a JAK2 positive myeloproliferative neoplasm. This indicates that the platelet aIIbβIII integrin has no role in venous thrombosis. We discuss the other potential mechanisms that are involved. In addition, we describe the successful use of dabigatran in this patient.
Original language | English |
---|---|
Article number | e04757 |
Pages (from-to) | 1-3 |
Journal | Clinical case reports |
Volume | 9 |
Issue number | 9 |
DOIs | |
Publication status | Published - Sept 2021 |
Keywords
- dabigatran
- Glanzmann thrombasthenia
- myeloproliferative neoplasm
- platelet
- venous thrombosis
- αIIbβIII integrin
- alpha IIb beta III integrin